Prospective Study Evaluating a Novel Mobile App Based Preventive

Status Not yet recruiting

Clinical Trial Summary

The primary aim of the study is to investigate whether a novel mobile App-based behavioral intervention in pregnant women can: (1) prevent and/or decrease the incidence of perinatal mood disorders (2) decrease the severity and/or duration of perinatal mood disorders in affected participants (3) increase access of pregnant women to behavioral intervention and support tools (4) increase the satisfaction of pregnant women with their prenatal care.

Clinical Trial Description

Perinatal depression is an episode of major or minor depression that occurs during pregnancy or in the 12 months after birth; it affects about 10% of new mothers. Postpartum depression accounts for 12.5% of psychologically related hospitalizations among women. In 2019, the United States Preventive Services Task Force (USPSTF) recommended screening pregnant women to identify those at risk for perinatal depression and refer them for counseling. The USPSTF recommendation is based on growing literature indicating that counseling women at risk for perinatal depression reduce the risk of having an episode of major depression by 40%. Supporting that, multiple studies have shown that cognitive-behavioral intervention and mental health care adjuvant therapy can effectively improve the condition of patients with postpartum depression. Finally, access to care has also been shown to be an important factor in determining the success of any intervention. Women across high and low-risk groups often have barriers to treatment due to stigma, shame, and fear to disclose symptoms to health providers In this research, the investigators aim to investigate whether a novel mobile App-based behavioral intervention can meaningfully increase access and demonstrate a beneficial effect in preventing anxiety and depression in the postpartum period. Furthermore and adding to the existing literature in post-partum depression, this study aims to investigate the role of "positive intelligence", an integrative positive cognitive behavioral therapy, as a tool in the prevention and treatment of perinatal mood disorders. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04914299
Study type	Interventional
Source	Massachusetts General Hospital
Contact	Shay Erisson, MD
Phone	6173322345
Email	serisson@partners.org
Status	Not yet recruiting
Phase	N/A
Start date	July 1, 2021
Completion date	July 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT04594525` - Maternal Telemental Health Interventions in Response to Covid-19*	N/A
Completed	`NCT04846504` - Accelerating Implementation of Mindful Mood Balance for Moms	N/A
Not yet recruiting	`NCT05175755` - Genetic Risk Factors Predictive of the Occurrence of Maternally Diagnosed Perinatal Depression in Women	N/A
Recruiting	`NCT05897619` - Feasibility and Acceptability of a Novel Cognitive Behavioral Skills Mobile App for Pregnant and Postpartum Individuals	N/A
Enrolling by invitation	`NCT04517981` - Cohort Study on the Outcome and Influencing Factors of Perinatal Depression
Completed	`NCT04094870` - A Pilot Trial of Perinatal Depression Treatment in HIV Infected Women	Phase 4
Completed	`NCT03291600` - Virtual Psychiatric Care for Perinatal Depression	N/A
Completed	`NCT03938350` - Dialectical Behavior Therapy for Pregnant Women	N/A
Active, not recruiting	`NCT04300894` - "Mamma Mia" for Perinatal Health and Wellness	N/A
Recruiting	`NCT05595486` - Baby2Home (B2H) Mobile Health Application	N/A
Completed	`NCT03336541` - Low-dose Ketamine and Postpartum Depression in Parturients With Prenatal Depression	Phase 4
Active, not recruiting	`NCT05393479` - "Thinking Healthy Programme" for Perinatal Depression in Nepal	N/A
Completed	`NCT05463926` - Effect of 'Parentbot - a Digital Healthcare Assistant (PDA)' in Improving Parenting Outcomes During the Perinatal Period	N/A
Completed	`NCT05119062` - The Feasibility of an Online Intergenerational Co-parenting Program	N/A
Enrolling by invitation	`NCT04838210` - Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care	N/A
Completed	`NCT03932760` - Telehealth Group Intervention for Perinatal Depressive Symptoms	N/A
Not yet recruiting	`NCT06364488` - TrueBlue Clinical Study - Investigating the Use of a Mobile Phone App TrueBlue for Monitoring Depression and Anxiety	N/A
Active, not recruiting	`NCT05196152` - MomMoodBooster VA Program	N/A
Completed	`NCT02935504` - PRogram In Support of Moms (PRISM): A Pilot Study	N/A
Not yet recruiting	`NCT05832424` - Feasibility and Acceptability of a Telehealth Intervention Among Women With Perinatal Mental Health	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Prospective Study Evaluating a Novel Mobile App Based Preventive Behavioral Intervention for Perinatal Mood Disorders

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms